Developer docs
API playgroundTry for free, no card

Search company profiles

Conceivex

Full company profile

uuid000ja2u

Namestring
Conceivex
Legal namestring
Conceivex, Inc.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Conceivex, Inc. is a Michigan-incorporated, privately held medical device company that designs, manufactures, and distributes the FDA 510(k)-cleared Conception Kit at-home system for fertility treatment. The company was founded by Michael La Vean and operates from Bloomfield Hills, Michigan, with 11-50 employees and is governed by a Board of Directors that includes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan.

The company's core technology is the Conception Cap, a one-size-fits-most, FDA-cleared cervical cap made from soft, implantable-grade silicone (General Electric Silopren, also used in heart replacement valves) with a patented collapsible dome that concentrates semen at the cervical os and a built-in removal loop. The cap is paired with a patented latex-free Semen Collector, a sperm-friendly intimate moisturizer, an ovulation predictor system (24 tests timed to the LH surge), a practice cap, pregnancy tests, a conception wheel, a journal, and an instruction manual to deliver a complete three-month treatment cycle. The mechanism addresses male-factor infertility (low count, low motility) and female-factor issues (hostile vaginal environment, cervix positioning) by protecting sperm from the vaginal pH environment where 90% of sperm reportedly die within 10 minutes during normal intercourse. FDA clearance demonstrated 24% conception in the first month of clinical use, 92% patient comprehension of instructions, and 84% ease-of-use rating; historical cervical cap efficacy ranges cited are 18-44%.

Conceivex operates a prescription-based hybrid B22C commercial model exclusively in the United States. Patients obtain prescriptions from physicians or through the eVisit telemedicine platform in select states, then fill the kit at major retail pharmacies (Walgreens, Walmart, Target, Rite Aid, HealthWarehouse.com) under standard pharmacy benefit coverage with co-pays reported as $0-$50, or purchase directly from Conceivex for a $399 out-of-pocket price with HSA/FSA eligibility. Target segments include couples in the initial 12 months of trying to conceive, men with low sperm count or motility, single mothers by choice, religious couples declining ART, military couples with limited conception windows, and women on fertility medication cycles seeking to maximize each cycle. There is no parent company, no public listing, no disclosed M&A activity, and one disclosed capital event of $2.55M dated 2015-08-25.

Short descriptiontext

Conceivex manufactures the FDA 510(k)-cleared Conception Kit at-home fertility system, sold by prescription through US retail pharmacies and telemedicine. The three-month kit combines a patented silicone cervical cap with ovulation predictors and accessories to address male and female factor infertility in non-clinical settings.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBloomfield Hills, United States
HQ citystring
Bloomfield Hills
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home fertility treatment, cervical cap insemination, fertility medical devices, reproductive health products, conception assistance
Industry2 codes
PRIMARYHLAHANAG
Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)
NAICS code2 codes
  • Medical Equipment and Supplies Manufacturing3391
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Fertility Medical Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Conception Kit Product Sales
TypeOne Time License
Description

One-time purchase of three-month Conception Kit at-home system; sold through pharmacies with insurance coverage (low copay) or direct purchase for out-of-pocket; prescription required in the United States; HSA and FSA eligible.

conceptionkit.com
2Pharmacy Benefit
TypeSubscription Recurring
Description

Kit covered under normal pharmacy benefit plans (not fertility rider); can be used during initial 12 months of trying to conceive; patients covered have co-pays as low as $25-$50.

conceptionkit.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Out-of-pocket purchase - three month supply
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$399 suggested retail price (some sources state $350 or $360); approximately $133 per month; covers 3-month treatment cycle

conceptionkit.com
2Insurance pharmacy benefit - three month supply
ModelSubscriptionBilling cadenceMonthly
Notes

$25-$50 copay for covered patients; covered under normal pharmacy benefit plan during initial 12 months of trying to conceive

conceptionkit.com
GTM typeB2C
B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1Conception Kit®
Description

The primary at-home system for couples trying to conceive, combining cervical cap insemination with ovulation timing. FDA-cleared for low sperm count, low sperm motility, and hostile vaginal environment.

conceptionkit.com
+2 more records
Core offering1 text field

Conceivex manufactures and distributes the Conception Kit at-home fertility treatment system, a three-month FDA 510(k)-cleared medical device that combines a cervical cap insemination device with ovulation predictors, a semen collector, and a sperm-friendly lubricant to help couples conceive naturally at home. The product is sold by prescription through US retail pharmacies and directly from the company, priced at $399 out-of-pocket or $0-$50 insurance copay as a covered pharmacy benefit.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 24% conception rate in first month of use in clinical trial
+5 more records
Product overview1 text field

Conceivex manufactures and distributes the Conception Kit® at-home system, a single unified FDA-cleared medical device for at-home fertility treatment. The product is a three-month comprehensive system that combines cervical cap insemination with timed intercourse to help couples overcome infertility. The kit includes the Conception Cap® (FDA-cleared cervical cap), Practice Conception Cap®, Conceivex Semen Collector, Conceivex Ovulation Predictors (24 tests), Sperm-Friendly Intimate Moisturizer, Pregnancy Tests, Conception Journal, Conception Wheel, and Instruction Manual. The Conception Kit is available by prescription only and covered by many insurance plans as a pharmacy benefit.

Product and service1 record
1Conception Kit At-Home System
CategoryFertility Medical Devices
Description

Three-month comprehensive at-home fertility treatment system combining a cervical cap insemination device with ovulation timing tools. FDA 510(k) cleared for low sperm count, low sperm motility, and hostile vaginal environment. Sold by prescription through US retail pharmacies or directly from Conceivex.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeTechnology or Integration
Description

Telemedicine integration partnership allowing patients to connect with OB/GYNs via secure video consultation for prescriptions; available in select states with expansion ongoing; enables remote prescription acquisition without in-person doctor visits

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Church & Dwight's First Response brand sells OTC ovulation and pregnancy tests in the same retail pharmacy channels (Walgreens, Target, Walmart, Rite Aid) as the Conception Kit, targeting the same end-customer segment of couples trying to conceive.

TypeDirect peer
Description

Clearblue (Swiss Precision Diagnostics) is a leading OTC ovulation and pregnancy test brand sold across major US retail pharmacies, directly competing for the same conception-timing wallet share that the Conception Kit's ovulation predictors address.

3Stork OTC (Rinovum Women's Health)
TypeDirect peer
Description

Rinovum previously commercialized Stork OTC, a competing at-home conception aid device targeting the same low-cost, non-clinical first-step positioning as the Conception Kit, making it the closest historical direct competitor in the at-home cervical-cap-style category.

TypeEmerging player
Description

Mira sells at-home quantitative fertility hormone monitors that compete with the Conception Kit's ovulation predictors as a more high-tech, app-connected alternative for couples trying to conceive naturally.

5Ava
TypeEmerging player
Description

Ava's wearable fertility tracker targets the same trying-to-conceive segment via continuous cycle monitoring, offering a non-device, non-prescription alternative that could substitute for the timing function in the Conception Kit.

TypeEmerging player
Description

Modern Fertility (acquired by Ro) sells at-home fertility hormone tests targeting women trying to conceive, addressing the same pre-treatment diagnostic step that often precedes OB/GYN referral to the Conception Kit.

TypeEmerging player
Description

Proov markets at-home PdG (progesterone metabolite) tests for ovulation confirmation, competing for the same ovulation-timing consumer education dollars and shelf space as the Conceivex Ovulation Predictors.

TypeEmerging player
Description

Natalist is a DTC women's reproductive health brand selling fertility-support products, ovulation tests, and prenatal supplements to the same target demographic of couples in the early stages of trying to conceive.

TypeBroad incumbent
Description

Church & Dwight owns First Response and broader personal care brands, giving it established mass-market retail distribution and marketing scale that could be leveraged to enter the at-home conception aid category if it became attractive enough.

10Fairhaven Health
TypeOthers
Description

Fairhaven Health sells fertility supplements and related products to couples trying to conceive, operating in an adjacent (nutraceutical) rather than device category but serving the same end customer and overlapping with the Conceivex content-marketing funnel.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Conceivex

Fertility Medical Devicesconceptionkit.com

Conceivex manufactures the FDA 510(k)-cleared Conception Kit at-home fertility system, sold by prescription through US retail pharmacies and telemedicine. The three-month kit combines a patented silicone cervical cap with ovulation predictors and accessories to address male and female factor infertility in non-clinical settings.

What Conceivex does

Conceivex, Inc. is a Michigan-incorporated, privately held medical device company that designs, manufactures, and distributes the FDA 510(k)-cleared Conception Kit at-home system for fertility treatment. The company was founded by Michael La Vean and operates from Bloomfield Hills, Michigan, with 11-50 employees and is governed by a Board of Directors that includes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan.

The company's core technology is the Conception Cap, a one-size-fits-most, FDA-cleared cervical cap made from soft, implantable-grade silicone (General Electric Silopren, also used in heart replacement valves) with a patented collapsible dome that concentrates semen at the cervical os and a built-in removal loop. The cap is paired with a patented latex-free Semen Collector, a sperm-friendly intimate moisturizer, an ovulation predictor system (24 tests timed to the LH surge), a practice cap, pregnancy tests, a conception wheel, a journal, and an instruction manual to deliver a complete three-month treatment cycle. The mechanism addresses male-factor infertility (low count, low motility) and female-factor issues (hostile vaginal environment, cervix positioning) by protecting sperm from the vaginal pH environment where 90% of sperm reportedly die within 10 minutes during normal intercourse. FDA clearance demonstrated 24% conception in the first month of clinical use, 92% patient comprehension of instructions, and 84% ease-of-use rating; historical cervical cap efficacy ranges cited are 18-44%.

Conceivex operates a prescription-based hybrid B22C commercial model exclusively in the United States. Patients obtain prescriptions from physicians or through the eVisit telemedicine platform in select states, then fill the kit at major retail pharmacies (Walgreens, Walmart, Target, Rite Aid, HealthWarehouse.com) under standard pharmacy benefit coverage with co-pays reported as $0-$50, or purchase directly from Conceivex for a $399 out-of-pocket price with HSA/FSA eligibility. Target segments include couples in the initial 12 months of trying to conceive, men with low sperm count or motility, single mothers by choice, religious couples declining ART, military couples with limited conception windows, and women on fertility medication cycles seeking to maximize each cycle. There is no parent company, no public listing, no disclosed M&A activity, and one disclosed capital event of $2.55M dated 2015-08-25.

Conceivex firmographics

Firmographics
Name
Conceivex
Legal name
Conceivex, Inc.
Website
https://conceptionkit.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Conceivex manufactures the FDA 510(k)-cleared Conception Kit at-home fertility system, sold by prescription through US retail pharmacies and telemedicine. The three-month kit combines a patented silicone cervical cap with ovulation predictors and accessories to address male and female factor infertility in non-clinical settings.
Ownership category
akta.pro rank

Conceivex industry classification

Industry
Product category
Fertility Medical Devices
NAICS
Medical Equipment and Supplies Manufacturing (3391), Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHANAG
Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Sterilization, Infection Prevention & Medical Disposables
SECONDARYCRABAIAK
Fertility & Ovulation Products (OTC)

Keywords

  • At-home fertility treatment
  • Cervical cap insemination
  • Fertility medical devices
  • Reproductive health products
  • Conception assistance

Where Conceivex is headquartered

Location

Headquarters

HQ city
Bloomfield Hills
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Conceivex business model

Business model
GTM type
B2C
Offering type
Hardware or Manufacturing
Cost components
Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Conception Kit Product Sales: One-time purchase of three-month Conception Kit at-home system; sold through pharmacies with insurance coverage (low copay) or direct purchase for out-of-pocket; prescription required in the United States; HSA and FSA eligible.
  2. Pharmacy Benefit: Kit covered under normal pharmacy benefit plans (not fertility rider); can be used during initial 12 months of trying to conceive; patients covered have co-pays as low as $25-$50.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goOut-of-pocket purchase - three month supply
SubscriptionMonthlyInsurance pharmacy benefit - three month supply

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Conceivex product offering

Product offering

Core offering

Conceivex manufactures and distributes the Conception Kit at-home fertility treatment system, a three-month FDA 510(k)-cleared medical device that combines a cervical cap insemination device with ovulation predictors, a semen collector, and a sperm-friendly lubricant to help couples conceive naturally at home. The product is sold by prescription through US retail pharmacies and directly from the company, priced at $399 out-of-pocket or $0-$50 insurance copay as a covered pharmacy benefit.

Product overview

Conceivex manufactures and distributes the Conception Kit® at-home system, a single unified FDA-cleared medical device for at-home fertility treatment. The product is a three-month comprehensive system that combines cervical cap insemination with timed intercourse to help couples overcome infertility. The kit includes the Conception Cap® (FDA-cleared cervical cap), Practice Conception Cap®, Conceivex Semen Collector, Conceivex Ovulation Predictors (24 tests), Sperm-Friendly Intimate Moisturizer, Pregnancy Tests, Conception Journal, Conception Wheel, and Instruction Manual. The Conception Kit is available by prescription only and covered by many insurance plans as a pharmacy benefit.

Differentiator

Problem solved

Functional benefit

Brands

  • Conception Kit®: The primary at-home system for couples trying to conceive, combining cervical cap insemination with ovulation timing. FDA-cleared for low sperm count, low sperm motility, and hostile vaginal environment.
  • Conception Cap®
  • Conceivex Ovulation Predictors

Products and services

  • Conception Kit At-Home System Three-month comprehensive at-home fertility treatment system combining a cervical cap insemination device with ovulation timing tools. FDA 510(k) cleared for low sperm count, low sperm motility, and hostile vaginal environment. Sold by prescription through US retail pharmacies or directly from Conceivex.

Quantifiable outcome

  • 24% conception rate in first month of use in clinical trial
  • +5 more outcomes

Companies that use Conceivex

Customer profile

Named customers3 records

Segments7 records

Ideal customer profiles2 records

Conceivex technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Conceivex partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • eVisitcoreTechnology or IntegrationTelemedicine integration partnership allowing patients to connect with OB/GYNs via secure video consultation for prescriptions; available in select states with expansion ongoing; enables remote prescription acquisition without in-person doctor visits

Scale indicators4 records

Recent moves4 records

Expansion highlights3 records

Conceivex competitors and assessment

Company assessment

Direct peers

  • First Response: Church & Dwight's First Response brand sells OTC ovulation and pregnancy tests in the same retail pharmacy channels (Walgreens, Target, Walmart, Rite Aid) as the Conception Kit, targeting the same end-customer segment of couples trying to conceive.
  • Clearblue: Clearblue (Swiss Precision Diagnostics) is a leading OTC ovulation and pregnancy test brand sold across major US retail pharmacies, directly competing for the same conception-timing wallet share that the Conception Kit's ovulation predictors address.
  • Stork OTC (Rinovum Women's Health): Rinovum previously commercialized Stork OTC, a competing at-home conception aid device targeting the same low-cost, non-clinical first-step positioning as the Conception Kit, making it the closest historical direct competitor in the at-home cervical-cap-style category.

Emerging players

  • Mira: Mira sells at-home quantitative fertility hormone monitors that compete with the Conception Kit's ovulation predictors as a more high-tech, app-connected alternative for couples trying to conceive naturally.
  • Ava: Ava's wearable fertility tracker targets the same trying-to-conceive segment via continuous cycle monitoring, offering a non-device, non-prescription alternative that could substitute for the timing function in the Conception Kit.
  • Modern Fertility (Ro): Modern Fertility (acquired by Ro) sells at-home fertility hormone tests targeting women trying to conceive, addressing the same pre-treatment diagnostic step that often precedes OB/GYN referral to the Conception Kit.
  • Proov: Proov markets at-home PdG (progesterone metabolite) tests for ovulation confirmation, competing for the same ovulation-timing consumer education dollars and shelf space as the Conceivex Ovulation Predictors.
  • Natalist: Natalist is a DTC women's reproductive health brand selling fertility-support products, ovulation tests, and prenatal supplements to the same target demographic of couples in the early stages of trying to conceive.

Broad incumbents

  • Church & Dwight: Church & Dwight owns First Response and broader personal care brands, giving it established mass-market retail distribution and marketing scale that could be leveraged to enter the at-home conception aid category if it became attractive enough.

Others

  • Fairhaven Health: Fairhaven Health sells fertility supplements and related products to couples trying to conceive, operating in an adjacent (nutraceutical) rather than device category but serving the same end customer and overlapping with the Conceivex content-marketing funnel.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Conceivex social profiles

Digital presence

Conceivex compliance and trust

Trust signal

Compliance1 record

Conceivex financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Conceivex leadership team

Management profile

Number of profiles

Profiles4 records

Conceivex funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Conceivex M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conceivex

What does Conceivex do?

Conceivex manufactures and distributes the Conception Kit at-home fertility treatment system, a three-month FDA 510(k)-cleared medical device that combines a cervical cap insemination device with ovulation predictors, a semen collector, and a sperm-friendly lubricant to help couples conceive naturally at home. The product is sold by prescription through US retail pharmacies and directly from the company, priced at $399 out-of-pocket or $0-$50 insurance copay as a covered pharmacy benefit.

Is Conceivex a public or private company?

Conceivex is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Conceivex founded?

Conceivex was founded in 2015. It employs 11 to 50 people.

Where is Conceivex based?

Conceivex is headquartered in Bloomfield Hills, United States, in the North America region.

How does Conceivex make money?

Two revenue lines are on record. Conception Kit Product Sales are the primary driver. The others are pharmacy Benefit.

Who are Conceivex's main competitors?

Direct peers on record are First Response, Clearblue and Stork OTC (Rinovum Women's Health). Emerging players are Mira, Ava, Modern Fertility (Ro), Proov and Natalist. Church & Dwight is listed as a broad incumbent. Fairhaven Health is listed as an others.

Does Conceivex have an API?

No public API is recorded for Conceivex.

What industry is Conceivex in?

Conceivex's product category is Fertility Medical Devices. Its primary akta.pro industry code is HLAHANAG, Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs), with a secondary code of CRABAIAK, Fertility & Ovulation Products (OTC). Its NAICS code is 3391 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireConceivex, Inc. Welcomes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan as Newest Members of Company's Board of DirectorsConceivex, Inc. added Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan to its board. The company's Conception Kit is an FDA-cleared at-home treatment for infertility, with over 250 babies conceived and nearly 20% of patients conceiving within 90 days.PrwebConceivex, Inc. Welcomes Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan as Newest Members of Company’s Board of DirectorsConceivex, Inc. added Adam Boris, Dr. David N. Madgy, and Jane Mary Sullivan to its board of directors. The company's Conception Kit is an FDA-cleared at-home treatment for infertility, with over 250 babies conceived and nearly 20% of patients conceiving within 90 days.GlobeNewswireConceivex Inc.'s Conception Kit(R) At-Home System Announces "Life Changing Results" Webinar, Helps Couples Understand Fertility OptionsConceivex Inc. will host a free webinar on Dec 2, 2015, to help couples understand fertility options. The webinar will cover the Conception Kit at-home system, an FDA-cleared cervical cap treatment for low sperm count and hostile vaginal environment. The system is available by prescription at most pharmacies nationwide.GlobeNewswireConception Kit(R) At-Home System Goes to Market, Helps Couples Get Pregnant During Regular Sex Launched By Conceivex, Inc.Conceivex, Inc. launched the Conception Kit at-home system, an FDA-cleared fertility treatment using a cervical cap to concentrate sperm at the cervical opening. The kit includes ovulation predictors and pregnancy tests, and is covered by insurance with a $20-$50 co-pay. It is available by prescription at major pharmacies nationwide.